Insulin long-acting (HM 12470) - Hanmi Pharmaceutical

Drug Profile

Insulin long-acting (HM 12470) - Hanmi Pharmaceutical

Alternative Names: LAPSInsulin 115; HM 12470; HM-12470A; SAR 440067

Latest Information Update: 16 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hanmi Pharmaceutical
  • Class Antihyperglycaemics; Insulins; Pancreatic hormones
  • Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 17 Aug 2017 Hanmi Pharmaceutical completes a phase I trial in healthy volunteers in USA (NCT03330327)
  • 01 May 2017 Hanmi Pharmaceutical completes a phase I trial in Type-1 and Type-2 diabetes mellitus in South Korea (SC) (NCT02302443)
  • 10 Jun 2016 Pharmacodynamics data from a preclinical study in presented at the 76th Annual Scientific Sessions of the American Diabetes Association (ADA-2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top